Comparative effects of dopamine and norepinephrine on myocardial function and metabolism during experimental cardiogenic shock.
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D004617:Embolism / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology*; D005260:Female; D006321:Heart / Q000503:physiopathology; D006331:Heart Diseases / Q000378:metabolism / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D012769:Shock / Q000503:physiopathology*; D014655:Vascular Resistance / Q000187:drug effects
D004298:Dopamine; D009638:Norepinephrine